---
title: "Edesa Biotech shares jump on $15M private placement"
date: "2025-02-13 16:45:44"
summary: "Edesa Biotech (NASDAQ:EDSA) shares rose more than 70% in Thursday pre-market trading after it said that it has sold, in a private placement, an aggregate of 834 newly designated Series B-1 convertible preferred shares and 3.5M common shares in a private placement priced at-the-market. The purchase price per preferred share..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Edesa Biotech (NASDAQ:[EDSA](https://seekingalpha.com/symbol/EDSA "Edesa Biotech, Inc.")) shares rose more than 70% in Thursday pre-market trading after it said that it has sold, in a [private placement](https://seekingalpha.com/pr/20001241-edesa-biotech-announces-15_0-million-private-placement-priced-at-the-market-under-nasdaq), an aggregate of 834 newly designated Series B-1 convertible preferred shares and 3.5M common shares in a private placement priced at-the-market.
* The purchase price per preferred share was $10,000 and the purchase price per common share was $1.92. Officers and directors of the company purchased approximately $1.1 million of the securities sold in the offering.
* Gross proceeds from the offering were approximately $15M before deducting any offering-related expenses.
* Edesa currently expects to use the net proceeds from the offering, to fund the continued advancement of EB06, its CXCL10 monoclonal antibody, into a Phase 2 clinical study in subjects with nonsegmental vitiligo, and for working capital and general corporate purposes.

[seekalpha](https://seekingalpha.com/news/4407684-edesa-biotech-shares-jump-on-15m-private-placement)
